Evaluation of the effects of photobiomodulation (808 nm) on pain and quality of life of diabetic neuropathy patients
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/25552 |
Resumo: | Diabetic neuropathy (DN) is one of the main complications of diabetes mellitus (DM), responsible for a high morbimortality rate and burdening public health resources. Photobiomodulation has proven to be effective in relieving pain, reducing the inflammation, and improving vascularization. We report an evaluation of the effectiveness of photobiomodulation for the relief of pain and to improve the quality of life in patients with diabetic neuropathy. A total of 30 diabetic volunteers with DN were randomly divided into three groups: control, photobiomodulation (PBM), and placebo (P-PBM). Those in Group control were instructed to take diabetic neuropathy medication for 30 days. The PBM group received laser photobiomodulation treatment with the following protocol: three sessions per week for 30 days, totaling 12 applications (wavelength, 808 nm; energy density, 12 J/cm²). in the of following nerves: tibial medial plantar, own plantar digital, common plantar digital, superficial fibular, deep fibular, sciatic, saphenous, and common fibular. Patients in the P-PBM Group were submitted to the PBM protocol, but with the device switched off. Before and after applying the therapeutic protocols, all volunteers were subjected to pain evaluations. The results showed a statistically significant difference between the groups (p < 0.05). The PBM group confirmed an analgesic effect directly related to the use of the photobiomodulation, whilst the patients in group control and P-PBM, did not present significant results. The study demonstrated that laser photobiomodulation is effective in significantly reducing pain and improving the quality of life of patients with diabetic neuropathy. |
id |
UNIFEI_2350789ce6ed086840afcc1418e62bde |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/25552 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Evaluation of the effects of photobiomodulation (808 nm) on pain and quality of life of diabetic neuropathy patientsEvaluación de los efectos de la fotobiomodulación (808 nm) sobre el dolor y la calidad de vida de los pacientes con neuropatía diabéticaAvaliação dos efeitos da fotobiomodulação (808 nm) na dor e na qualidade de vida de pacientes com neuropatia diabéticaDiabetes mellitusNeuropatias diabéticasDorFotobiomodulação.Diabetes mellitusNeuropatías diabéticasDolorFotobiomodulación.Diabetes mellitusDiabetic neuropathiesPainPhotobiomodulation.Diabetic neuropathy (DN) is one of the main complications of diabetes mellitus (DM), responsible for a high morbimortality rate and burdening public health resources. Photobiomodulation has proven to be effective in relieving pain, reducing the inflammation, and improving vascularization. We report an evaluation of the effectiveness of photobiomodulation for the relief of pain and to improve the quality of life in patients with diabetic neuropathy. A total of 30 diabetic volunteers with DN were randomly divided into three groups: control, photobiomodulation (PBM), and placebo (P-PBM). Those in Group control were instructed to take diabetic neuropathy medication for 30 days. The PBM group received laser photobiomodulation treatment with the following protocol: three sessions per week for 30 days, totaling 12 applications (wavelength, 808 nm; energy density, 12 J/cm²). in the of following nerves: tibial medial plantar, own plantar digital, common plantar digital, superficial fibular, deep fibular, sciatic, saphenous, and common fibular. Patients in the P-PBM Group were submitted to the PBM protocol, but with the device switched off. Before and after applying the therapeutic protocols, all volunteers were subjected to pain evaluations. The results showed a statistically significant difference between the groups (p < 0.05). The PBM group confirmed an analgesic effect directly related to the use of the photobiomodulation, whilst the patients in group control and P-PBM, did not present significant results. The study demonstrated that laser photobiomodulation is effective in significantly reducing pain and improving the quality of life of patients with diabetic neuropathy.La neuropatía diabética (ND) es una de las principales complicaciones de la diabetes mellitus (DM), responsable de una alta tasa de morbimortalidad y sobrecarga de los recursos de salud pública. La fotobiomodulación ha demostrado ser eficaz para aliviar el dolor, reducir la inflamación y mejorar la vascularización. Presentamos una evaluación de la efectividad de la fotobiomodulación para el alivio del dolor y para mejorar la calidad de vida en pacientes con neuropatía diabética. Un total de 30 voluntarios diabéticos con DN se dividieron aleatoriamente en tres grupos: control, fotobiomodulación (PBM) y placebo (P-PBM). A los del grupo control se les indicó que tomaran medicación para la neuropatía diabética durante 30 días. El grupo PBM recibió tratamiento de fotobiomodulación láser con el siguiente protocolo: tres sesiones por semana durante 30 días, totalizando 12 aplicaciones (longitud de onda, 808 nm; densidad de energía, 12 J / cm²). en los siguientes nervios: tibial medial plantar, propio plantar digital, plantar común digital, peroné superficial, peroné profundo, ciático, safeno y peroné común. Los pacientes del grupo P-PBM se sometieron al protocolo PBM, pero con el dispositivo apagado. Antes y después de la aplicación de los protocolos terapéuticos, todos los voluntarios fueron sometidos a evaluaciones de dolor. Los resultados mostraron una diferencia estadísticamente significativa entre los grupos (p <0.05). El grupo PBM confirmó un efecto analgésico directamente relacionado con el uso de la fotobiomodulación, mientras que los pacientes del grupo control y P-PBM, no presentaron resultados significativos. El estudio demostró que la fotobiomodulación con láser es eficaz para reducir significativamente el dolor y mejorar la calidad de vida de los pacientes con neuropatía diabética.A neuropatia diabética (ND) é uma das principais complicações do diabetes mellitus (DM), responsável por elevada taxa de morbimortalidade e onerando recursos públicos de saúde. A fotobiomodulação tem se mostrado eficaz no alívio da dor, reduzindo a inflamação e melhorando a vascularização. Nós relatamos uma avaliação da eficácia da fotobiomodulação para o alívio da dor e para melhorar a qualidade de vida em pacientes com neuropatia diabética. Um total de 30 voluntários diabéticos com ND foram divididos aleatoriamente em três grupos: controle, fotobiomodulação (PBM) e placebo (P-PBM). Os do Grupo controle foram orientados a tomar medicação para neuropatia diabética por 30 dias. O grupo PBM recebeu tratamento de fotobiomodulação a laser com o seguinte protocolo: três sessões semanais durante 30 dias, totalizando 12 aplicações (comprimento de onda, 808 nm; densidade de energia, 12 J / cm²). nos seguintes nervos: tibial medial plantar, plantar digital próprio, digital plantar comum, fibular superficial, fibular profundo, ciático, safeno e fibular comum. Os pacientes do Grupo P-PBM foram submetidos ao protocolo PBM, porém com o aparelho desligado. Antes e após a aplicação dos protocolos terapêuticos, todos os voluntários foram submetidos a avaliações de dor. Os resultados mostraram diferença estatisticamente significativa entre os grupos (p <0,05). O grupo PBM confirmou um efeito analgésico diretamente relacionado ao uso da fotobiomodulação, enquanto os pacientes do grupo controle e P-PBM, não apresentaram resultados significativos. O estudo demonstrou que a fotobiomodulação a laser é eficaz na redução significativa da dor e na melhoria da qualidade de vida de pacientes com neuropatia diabética.Research, Society and Development2022-01-24info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2555210.33448/rsd-v11i2.25552Research, Society and Development; Vol. 11 No. 2; e26211225552Research, Society and Development; Vol. 11 Núm. 2; e26211225552Research, Society and Development; v. 11 n. 2; e262112255522525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/25552/22528Copyright (c) 2022 Milena Valdinéia da Silva Leal; Mário Oliveira Lima; Davidson Ribeiro Costa; Renata Amadei Nicolau; Luana Aparecida Pilato Ribeiro; David Ribeiro Costa; Teresa Marly Teles de Carvallho; Kelson Nonato Gomes da Silva; Diego Rodrigues Pessoa; Emilia Angela Lo Schiavo Arisawahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessLeal, Milena Valdinéia da Silva Lima, Mário Oliveira Costa, Davidson Ribeiro Nicolau, Renata Amadei Ribeiro, Luana Aparecida Pilato Costa, David Ribeiro Carvallho, Teresa Marly Teles de Silva, Kelson Nonato Gomes da Pessoa, Diego Rodrigues Arisawa, Emilia Angela Lo Schiavo 2022-02-07T01:42:50Zoai:ojs.pkp.sfu.ca:article/25552Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:43:48.652540Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Evaluation of the effects of photobiomodulation (808 nm) on pain and quality of life of diabetic neuropathy patients Evaluación de los efectos de la fotobiomodulación (808 nm) sobre el dolor y la calidad de vida de los pacientes con neuropatía diabética Avaliação dos efeitos da fotobiomodulação (808 nm) na dor e na qualidade de vida de pacientes com neuropatia diabética |
title |
Evaluation of the effects of photobiomodulation (808 nm) on pain and quality of life of diabetic neuropathy patients |
spellingShingle |
Evaluation of the effects of photobiomodulation (808 nm) on pain and quality of life of diabetic neuropathy patients Leal, Milena Valdinéia da Silva Diabetes mellitus Neuropatias diabéticas Dor Fotobiomodulação. Diabetes mellitus Neuropatías diabéticas Dolor Fotobiomodulación. Diabetes mellitus Diabetic neuropathies Pain Photobiomodulation. |
title_short |
Evaluation of the effects of photobiomodulation (808 nm) on pain and quality of life of diabetic neuropathy patients |
title_full |
Evaluation of the effects of photobiomodulation (808 nm) on pain and quality of life of diabetic neuropathy patients |
title_fullStr |
Evaluation of the effects of photobiomodulation (808 nm) on pain and quality of life of diabetic neuropathy patients |
title_full_unstemmed |
Evaluation of the effects of photobiomodulation (808 nm) on pain and quality of life of diabetic neuropathy patients |
title_sort |
Evaluation of the effects of photobiomodulation (808 nm) on pain and quality of life of diabetic neuropathy patients |
author |
Leal, Milena Valdinéia da Silva |
author_facet |
Leal, Milena Valdinéia da Silva Lima, Mário Oliveira Costa, Davidson Ribeiro Nicolau, Renata Amadei Ribeiro, Luana Aparecida Pilato Costa, David Ribeiro Carvallho, Teresa Marly Teles de Silva, Kelson Nonato Gomes da Pessoa, Diego Rodrigues Arisawa, Emilia Angela Lo Schiavo |
author_role |
author |
author2 |
Lima, Mário Oliveira Costa, Davidson Ribeiro Nicolau, Renata Amadei Ribeiro, Luana Aparecida Pilato Costa, David Ribeiro Carvallho, Teresa Marly Teles de Silva, Kelson Nonato Gomes da Pessoa, Diego Rodrigues Arisawa, Emilia Angela Lo Schiavo |
author2_role |
author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Leal, Milena Valdinéia da Silva Lima, Mário Oliveira Costa, Davidson Ribeiro Nicolau, Renata Amadei Ribeiro, Luana Aparecida Pilato Costa, David Ribeiro Carvallho, Teresa Marly Teles de Silva, Kelson Nonato Gomes da Pessoa, Diego Rodrigues Arisawa, Emilia Angela Lo Schiavo |
dc.subject.por.fl_str_mv |
Diabetes mellitus Neuropatias diabéticas Dor Fotobiomodulação. Diabetes mellitus Neuropatías diabéticas Dolor Fotobiomodulación. Diabetes mellitus Diabetic neuropathies Pain Photobiomodulation. |
topic |
Diabetes mellitus Neuropatias diabéticas Dor Fotobiomodulação. Diabetes mellitus Neuropatías diabéticas Dolor Fotobiomodulación. Diabetes mellitus Diabetic neuropathies Pain Photobiomodulation. |
description |
Diabetic neuropathy (DN) is one of the main complications of diabetes mellitus (DM), responsible for a high morbimortality rate and burdening public health resources. Photobiomodulation has proven to be effective in relieving pain, reducing the inflammation, and improving vascularization. We report an evaluation of the effectiveness of photobiomodulation for the relief of pain and to improve the quality of life in patients with diabetic neuropathy. A total of 30 diabetic volunteers with DN were randomly divided into three groups: control, photobiomodulation (PBM), and placebo (P-PBM). Those in Group control were instructed to take diabetic neuropathy medication for 30 days. The PBM group received laser photobiomodulation treatment with the following protocol: three sessions per week for 30 days, totaling 12 applications (wavelength, 808 nm; energy density, 12 J/cm²). in the of following nerves: tibial medial plantar, own plantar digital, common plantar digital, superficial fibular, deep fibular, sciatic, saphenous, and common fibular. Patients in the P-PBM Group were submitted to the PBM protocol, but with the device switched off. Before and after applying the therapeutic protocols, all volunteers were subjected to pain evaluations. The results showed a statistically significant difference between the groups (p < 0.05). The PBM group confirmed an analgesic effect directly related to the use of the photobiomodulation, whilst the patients in group control and P-PBM, did not present significant results. The study demonstrated that laser photobiomodulation is effective in significantly reducing pain and improving the quality of life of patients with diabetic neuropathy. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-01-24 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/25552 10.33448/rsd-v11i2.25552 |
url |
https://rsdjournal.org/index.php/rsd/article/view/25552 |
identifier_str_mv |
10.33448/rsd-v11i2.25552 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/25552/22528 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 11 No. 2; e26211225552 Research, Society and Development; Vol. 11 Núm. 2; e26211225552 Research, Society and Development; v. 11 n. 2; e26211225552 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052702642929664 |